Stem Cells
17
2
2
6
Key Insights
Highlights
Success Rate
86% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
5.9%
1 terminated out of 17 trials
85.7%
-0.8% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (17)
AlloGeneic Human Mesenchymal Stem Cells (hMSC) in PAtients With FistuLizing Crohn's Disease Via PErifistula iNjEctions (GALENE)
Insulin Producing Stem Cell Transplantation Clinical Trial in Type 1 Diabetes
Fertility Enhancement Through Regenerative Treatment in Ovaries and Testes
The Acute Effect of a Theacrine-based Supplement on Mobilization of Various Stem Cell Populations.
Safety Study of Stemchymal® in Acute Liver Failure
MRG-001 as an Immunoregulatory and Regenerative Therapy for COVID-19 Patients
Impact of Obesity, Chronic Kidney Disease and Type 2 Diabetes on Human Urinary Stem Cells
Allogeneic Mesenchymal Stem Cells for Radiation-induced Hyposalivation and Xerostomia/Dry Mouth
The Effects of Antibiotic Combinations on Stem Cells
Stem Cells After Peripheral Mobilization and Harvest
Stem Cell Collection
Effect of Weight Loss Surgery on Stem Cells.
Placental Transfusion Methods and Stem Cells
Intra-articular Injection of MSCs in Treatment of Knee OA
Intracavernous Injection of Autologous Mesenchymal Stem Cells in the Treatment of Erectile Dysfunction Resistant to Oral Treatment in Patients With Type I Diabetes
Treatment of Osteoarthritis With the Stromal Vascular Fraction of Abdominal Adipose Tissue - a Pilot Study
Isolation and Characterization of Mammary Stem Cells